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Regarding the Di George syndrome, we had 222 patients iden-
tified by means of the FISH test; in our institution the FISH test
was started routinely for conal truncal abnormalities around Jan-
uary 1995. Therefore probably we missed something, but I think
this is a common problem for other workers I have seen in
literature.
Dr Thomas L. Spray (Philadelphia, Pa). I just had a ques-
tion, and it might be in your article, but in your new classifi-
cation, when you are talking about confluent, I assume, intra-
parenchymal pulmonary arteries, you mentioned that it is
unilateral or bilateral.
Was there any difference in terms of outcome, whether it
was unilateral or bilateral, and did that determine whether you
tried to do a single-stage unifocalization or a staged unifocal-
ization?
Dr Griselli. No, there was no difference between unilateral or
bilateral confluent intrapulmonary PAs.
There were differences between unilateral and bilateral com-
pared with the MAPCAs, definitely in outcome. The patient had
only MAPCAs. That was the only difference noted, not between
unilateral or bilateral, no.
Dr Adriano Carotti (Rome, Italy). Did you find any difference
between the single-stage approach and the multistage approach
either in terms of hemodynamic results, namely, the RV/LV pres-
sure ratio after VSD closure, or of major perioperative morbidity,
such as a paralysis of the phrenic nerve.
Furthermore, concerning 22Q11 microdeletion, which occurred
in our experiences as much as 40% of cases and related signifi-
cantly with postsurgical prognosis, I would like to know whether,
in your series, chromosome 22Q11 microdeletion affected periop-
erative mortality, morbidity, or both at all.
Dr Griselli. There was no difference in terms of complication
for different groups. We had 21 major complications, complica-
tions that required intervention, and there were no differences
within the 3 groups.
Regarding the microdeletion, again, there were no differences
among the 3 groups, although we reviewed the data from another
point of view, because this is just an aspect of the MAPCA
surgery. Our idea is that we want to explain why some patients
who basically had a better anatomy, such as intrapulmonary pul-
monary arteries, require more reoperation, but we are looking at
this for a further study.
Dr Antonio F. Corno (Lausanne, Switzerland). What are the
consequences of your study? On the basis of the observation you
reported, did you change any policy in your approach to these
patients? Are you considering any change, particularly in the group
of patients with MAPCAs only?
Dr Griselli. There is no change in terms of the operation, but
what before was important for us, like finding the intrapericardial
pulmonary arteries in terms of results, now we focus more on
finding confluence at the intrapulmonary level, which seems to be
a more important thing for a surgeon to find the confluence
between the chest and the hilum. Then you can join them up
centrally, as you like.
But more important is not just what you can find inside the
pericardium but what you can find in the hilum of the lungs. If you
find a good confluence, it is a good prognostic factor, even if you
do not have intrapericardial PAs.
Surgery for Congenital Heart Disease Griselli et al
258 The Journal of Thoracic and Cardiovascular Surgery ● January 2004
CH
D
